BioCentury
ARTICLE | Company News

Archimedes submits NasalFent MAA

April 28, 2009 1:32 AM UTC

Archimedes Pharma Ltd. (Reading, U.K.) submitted an MAA to EMEA for NasalFent fentanyl nasal spray to treat breakthrough cancer pain. NasalFent uses the company's PecSys nasal spray drug delivery syst...